Research location
Montebello
California, United States
Advertisement
Research activity in Montebello
California, United StatesCureCurrent currently publishes aggregate city-level research activity for this location: 48 trials and 52 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Montebello
48 linked trials · page 1 of 1A Study of Orforglipron in Female Participants With Stress Urinary Incontinence Who Have Obesity or OverweightNCT07202884 · 2025-09-30 · 1 site observation
RECRUITING
64Cu-SAR-bisPSMA Positron Emission Tomography: A Phase 3 Study of Participants With Biochemical Recurrence of Prostate CancerNCT06970847 · 2025-05-16 · 1 site observation
ACTIVE_NOT_RECRUITING
A Dose Finding Study of Debio 4228 in Participants With Advanced Prostate CancerNCT06395753 · 2024-05-23 · 1 site observation
COMPLETED
Saruparib (AZD5305) vs Placebo in Men With Metastatic Castration-Sensitive Prostate Cancer Receiving Physician's Choice New Hormonal AgentsNCT06120491 · 2023-11-21 · 1 site observation
ACTIVE_NOT_RECRUITING
A Comparison of TULSA Procedure vs. Radical Prostatectomy in Participants With Localized Prostate CancerNCT05027477 · 2021-11-01 · 1 site observation
ACTIVE_NOT_RECRUITING
Phase II Trial of HM61713 for the Treatment of ≥2nd Line T790M Mutation Positive Adenocarcinoma of the LungNCT02485652 · 2015-08-31 · 1 site observation
TERMINATED
Effectiveness of Aurix Therapy in Diabetic Foot UlcersNCT02352480 · 2015-01-01 · 1 site observation
UNKNOWN
Efficacy and Safety Study of Bimatoprost Sustained-Release (SR) in Participants With Open-angle Glaucoma or Ocular HypertensionNCT02247804 · 2014-12-15 · 1 site observation
COMPLETED
Culturally Tailoring a Stroke Intervention in Community Senior CentersNCT02181062 · 2014-10-01 · 1 site observation
COMPLETED
Safety and Efficacy Study of Abraxane as Maintenance Treatment After Abraxane Plus Carboplatin in 1st Line Stage IIIB / IV Squamous Cell Non-small Cell Lung CancerNCT02027428 · 2014-02-11 · 1 site observation
COMPLETED
Multicenter Post-Approval Study Of The Glaukos® iStent® Trabecular Micro-Bypass Stent System In Conjunction With Cataract SurgeryNCT01841450 · 2013-07-01 · 1 site observation
UNKNOWN
AqueSys XEN 45 Glaucoma Implant in Refractory GlaucomaNCT02036541 · 2013-01-01 · 1 site observation
COMPLETED
Study of Cabozantinib (XL184) Versus Prednisone in Men With Metastatic Castration-resistant Prostate Cancer Previously Treated With Docetaxel and Abiraterone or MDV3100NCT01605227 · 2012-07-01 · 1 site observation
COMPLETED
A Safety and Efficacy Study of Farletuzumab in Participants With Adenocarcinoma of the LungNCT01218516 · 2011-06-27 · 1 site observation
COMPLETED
A Study of Trastuzumab Emtansine (T-DM1) Plus Pertuzumab/Pertuzumab Placebo Versus Trastuzumab [Herceptin] Plus a Taxane in Participants With Metastatic Breast Cancer (MARIANNE)NCT01120184 · 2010-07-31 · 1 site observation
COMPLETED
BIBW 2992 (Afatinib) Versus Chemotherapy as First Line Treatment in NSCLC With EGFR MutationNCT00949650 · 2009-08-14 · 1 site observation
COMPLETED
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving ChemotherapyNCT00858364 · 2009-07-17 · 1 site observation
TERMINATED
Study of Sotatercept for the Treatment of Chemotherapy Induced Anemia in Patients With Metastatic Breast Cancer (MK-7962-012)NCT00931606 · 2009-06-01 · 1 site observation
TERMINATED
A Clinical Trial Comparing the Combination of TC Plus Bevacizumab to TC Alone and to TAC for Women With Node-Positive or High-Risk Node-Negative, HER2-Negative Breast CancerNCT00887536 · 2009-05-01 · 1 site observation
COMPLETED
A Study of Trastuzumab Emtansine Versus Capecitabine + Lapatinib in Participants With HER2-positive Locally Advanced or Metastatic Breast CancerNCT00829166 · 2009-02-01 · 1 site observation
COMPLETED
A Randomized Trial Of PF-00299804 Taken Orally Versus Erlotinib Taken Orally For Treatment Of Advanced Non-Small Cell Lung Cancer That Has Progressed After One Or Two Prior Chemotherapy RegimenNCT00769067 · 2008-11-01 · 1 site observation
COMPLETED
Chemotherapy and Lapatinib or Trastuzumab in Treating Women With HER2/Neu-Positive Metastatic Breast CancerNCT00667251 · 2008-10-07 · 1 site observation
COMPLETED
Study of Telintra for Treatment of Chemotherapy Induced Neutropenia in Patients With Non-Small Cell Lung CancerNCT00701870 · 2008-10-01 · 1 site observation
TERMINATED
Electronic Xoft Intersociety Brachytherapy Trial: Electronic Brachytherapy (EBT) For Treatment of Early Stage Breast CancerNCT00742222 · 2008-05-01 · 1 site observation
COMPLETED
BIBW 2992 and BSC Versus Placebo and BSC in Non-small Cell Lung Cancer Patients Failing Erlotinib or Gefitinib (LUX-LUNG 1)NCT00656136 · 2008-04-01 · 1 site observation
COMPLETED
QUILT-2.015: A Study of AMG 479 With Exemestane or Fulvestrant in Postmenopausal Women With Hormone Receptor Positive Locally Advanced or Metastatic Breast CancerNCT00626106 · 2008-03-27 · 1 site observation
COMPLETED
Phase II Study for Previously Untreated Subjects With Non Small Cell Lung Cancer (NSCLC) or Small Cell Lung Cancer (SCLC)NCT00527735 · 2008-02-01 · 1 site observation
COMPLETED
Study of Ruxolitinib (INCB018424) Administered Orally to Patients With Androgen Independent Metastatic Prostate CancerNCT00638378 · 2008-02-01 · 1 site observation
TERMINATED
GSK1572932A Antigen-Specific Cancer Immunotherapeutic as Adjuvant Therapy in Patients With Non-Small Cell Lung CancerNCT00480025 · 2007-10-04 · 1 site observation
TERMINATED
CT-2103/Carboplatin vs Paclitaxel/Carboplatin for NSCLC in Women With Estradiol > 25 pg/mLNCT00576225 · 2007-09-01 · 1 site observation
WITHDRAWN
Carboplatin With Either Paclitaxel Poliglumex or Paclitaxel in Treating Women With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung CancerNCT00551733 · 2007-08-01 · 1 site observation
TERMINATED
A Study In Patients With Non-Small Cell Lung Cancer To Test If Erlotinib Plus SU011248 Is Better Than Erlotinib AloneNCT00457392 · 2007-07-01 · 1 site observation
COMPLETED
A Study Of Sunitinib In Combination With Capecitabine Compared With Capecitabine In Patients With Breast CancerNCT00435409 · 2007-02-01 · 1 site observation
COMPLETED
Cancer Vaccine Study for Unresectable Stage III Non-small Cell Lung Cancer (START)NCT00409188 · 2007-01-01 · 1 site observation
COMPLETED
XeNA Study - A Study of Xeloda (Capecitabine) in Patients With Invasive Breast CancerNCT00127933 · 2005-08-01 · 1 site observation
COMPLETED
Study of Taxane/Carboplatin +/- Cetuximab as First-Line Treatment for Patients With Advanced/Metastatic Non-Small Cell Lung CancerNCT00112294 · 2004-12-01 · 1 site observation
COMPLETED
A Study to Evaluate Tarceva in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)NCT00091663 · 2004-08-01 · 1 site observation
COMPLETED
GVAX® Vaccine for Prostate Cancer vs Docetaxel & Prednisone in Patients With Metastatic Hormone-Refractory Prostate CancerNCT00089856 · 2004-07-01 · 1 site observation
TERMINATED
Study Evaluating CCI-779 and Letrozole in Post-menopausal Women With Breast CancerNCT00083993 · 2004-05-01 · 1 site observation
TERMINATED
Non-small Cell Lung Cancer Study US75 (Z-PACT)NCT00086268 · 2004-04-01 · 1 site observation
COMPLETED
AG-013736 In Combination With Docetaxel Versus Docetaxel Alone For Patients With Metastatic Breast CancerNCT00076024 · 2004-02-01 · 1 site observation
COMPLETED
Study Comparing Lapatinib (GW572016) And Letrozole Versus Letrozole In Subjects With Advanced Or Metastatic Breast CancerNCT00073528 · 2003-12-09 · 1 site observation
COMPLETED
Polyglutamate Paclitaxel Plus Carboplatin Compared With Paclitaxel Plus Carboplatin in Treating Patients With Advanced or Recurrent Non-Small Cell Lung CancerNCT00054210 · 2003-01-01 · 1 site observation
TERMINATED
A Phase II Study of CI-1033 in Treating Patients With Metastatic (Stage IV) Breast CancerNCT00051051 · 2002-12-01 · 1 site observation
COMPLETED
Zoledronic Acid - Letrozole Adjuvant Synergy Trial (ZFAST) - Cancer Treatment Related Bone Loss in Postmenopausal Women With Estrogen Receptor Positive and/or Progesterone Receptor Positive Breast Cancer Receiving Adjuvant Hormonal TherapyNCT00050011 · 2002-09-01 · 1 site observation
COMPLETED
Iressa Expanded Access Program (EAP)NCT00034879 · 2000-08-01 · 1 site observation
COMPLETED
Study of TLK286 (Telcyta) vs. Gefitinib in Locally Advanced or Metastatic Non-Small Cell Lung CancerNCT00080340 · 5 site observations
COMPLETED
Study of Neurologic Progression With Motexafin Gadolinium and Radiation Therapy (SMART)NCT00054795 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.